C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 110 filers reported holding C4 THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $143,385 | -47.8% | 45,664 | -1.9% | 0.00% | – |
| Q4 2022 | $274,498 | -31.9% | 46,525 | +1.2% | 0.00% | -100.0% |
| Q3 2022 | $403,000 | +14.5% | 45,995 | -1.5% | 0.00% | 0.0% |
| Q2 2022 | $352,000 | -46.0% | 46,718 | +73.8% | 0.00% | 0.0% |
| Q1 2022 | $652,000 | -35.1% | 26,885 | -13.8% | 0.00% | 0.0% |
| Q4 2021 | $1,004,000 | -24.4% | 31,191 | +4.9% | 0.00% | -50.0% |
| Q3 2021 | $1,328,000 | -26.1% | 29,732 | -37.4% | 0.00% | 0.0% |
| Q2 2021 | $1,797,000 | +201.0% | 47,489 | +194.2% | 0.00% | +100.0% |
| Q1 2021 | $597,000 | +11.6% | 16,140 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $535,000 | – | 16,140 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $17,795,000 | 7.09% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $60,745,000 | 3.44% |
| Soleus Capital Management, L.P. | 464,068 | $17,166,000 | 3.09% |
| Cormorant Asset Management, LP | 2,490,065 | $92,107,000 | 2.05% |
| P.A.W. CAPITAL CORP | 50,000 | $1,850,000 | 1.63% |
| Perceptive Advisors | 3,158,566 | $116,835,000 | 1.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 497,136 | $18,389,000 | 1.41% |
| Mizuho Securities Co. Ltd. | 169,392 | $6,266,000 | 1.30% |
| RTW INVESTMENTS, LP | 2,149,228 | $79,437,000 | 1.24% |
| Darwin Global Management, Ltd. | 140,034 | $5,180,000 | 1.01% |